The Atopic Dermatitis Countdown: Ready, Set, Go!
Medium: Online Module
Commercial Support: Support for this activity has been provided through and independent educational grant from LEO Pharma A/S and LEO Pharma Inc.
After completing this activity, participants will be able to:
- Have increased knowledge regarding the
- Burden of atopic dermatitis;
- Role of interleukin (IL)-13 in the pathophysiology of atopic dermatitis;
- Current evidence for new and emerging biologic agents for the treatment of atopic dermatitis.
Clinical Assistant Professor of Dermatology and Pediatrics
Feinberg School of Medicine
Chicago Integrative Eczema Center
Oregon Medical Research Center
Section of Dermatology
The University of Chicago Medicine
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University Of Chicago Pritzker School Of Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.